# Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

> **NCT00646100** · PHASE4 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 164 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** transcatheter arterial chemoembolization

## Key facts

- **NCT ID:** NCT00646100
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2009-07
- **Final completion:** 2010-02
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2012-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00646100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00646100, "Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00646100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*